Company Description
Like B. B. King but without the guitar, health benefits provider WellPoint is the king of the Blues. Through its subsidiaries, the firm provides...
Key WellPoint Financials
| Company Type | Public - NYSE: WLP Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $61,134.3 |
| 2007 Employees | 41,700 |
More WellPoint Financials (11 pages)
Latest WellPoint Jobs powered by Monster.com
- Cust Care Rep I - Multi - 33360EB
- Cust Care Rep I - Multi - 33360EB
- Nurse Case Mgr Sr (Job Family)
Rankings
- #33 in FORTUNE 500
- S&P 500
- #157 in FT Global 500
Competition
Competitive Landscape for Insurance Carriers
Demand is driven by demographics and commercial transactions. The profitability of individual companies depends on effective marketing and on the ability to accurately estimate future payments. Large...
Read more about WellPoint's competition across multiple industries
Top WellPoint Competitors
Sponsored Links
The Business DirectoryWellPoint Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman | Larry C. Glasscock | Network | E-mail |
| EVP; President and CEO Operations, Technology and Government Services Bursiness Unit | Mark L. Boxer | Network | E-mail |
| President, CEO, and Director | Angela F. Braly | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Current WellPoint News
- Wellpoint Inc(GAAP) (WLP.GP) Weekly Earnings Information [Nelson Information - Weekly Domestic] (11 May 2008 05:11:00 EDT)
- Wellpoint Systems Inc(C$) (WPS.CA) Weekly Earnings Information [Nelson Information - Weekly Domestic] (11 May 2008 02:59:00 EDT)
-
Wellpoint Inc (NYSE:WLP) Weekly Earnings Information [Nelson Information - Weekly Domestic] (11 May 2008 01:13:00 EDT)
Latest Industry Video
-
ASCO 2007 Preview (5:07)
06/01/07 8:50AM ET - Wachovia Capital Markets Senior Biotech Analyst George Farmer and Miller Tabak Pharmaceutical Analyst Les Fundleyder discuss new drugs coming out at this year's conference.






